Vaccination with
allergen-encoding
DNA has been proposed as having potential for
allergen-specific
immunotherapy. In this study, we examine the
therapeutic effect of
allergen-encoding
DNA vaccination directly to dendritic cells (DCs) on
allergen-induced allergic airway
inflammation in a mouse model and explore potential mechanism.
Ovalbumin (OVA)-sensitized and challenged mice were immunized with
DNA vaccine and received bronchoalveolar lavage (BAL) 1 day after the last challenge, to measure BAL levels of
interleukin (IL)-4,
IL-5,
interferon (IFN)-gamma and differential cell count. Pulmonary DCs and Spleen DCs were purified and sorted according to the expression of CD(11c) (+)CD(80) (+) and CD(11c) (+)CD(86) (+) co-stimulatory molecules. Our data demonstrated that
DNA vaccine therapy with OVA-Fc-pcDNA(3.1) significantly prevented OVA-increased levels of
IL-4,
IL-5 and the percentage of eosinophils and OVA-decreased level of IFN-gamma. OVA-Fc-pcDNA(3.1)-treated mice had less severity of airway
inflammation, and lower expression of CD(11c) (+)CD(80) (+) and CD(11c) (+)CD(86) (+) on pulmonary DCs, as compared with animals with OVA-pcDNA(3.1,) pcDNA(3.1) and OVA respectively.
DNA vaccine encoding both Fc and OVA was shown to be more effective than
DNA vaccine encoding OVA alone. Our data indicate that Fc-
antigen combination-encoding
DNA vaccination has better preventive effects on
antigen-induced airway
inflammation by regulating DCs, and may be a new alternative
therapy for
asthma.